Routine Screenings For Mild Thyroid Disorder Recommended

July 23, 1996

Like routine screenings for high blood pressure and breast cancer, screening for an underactive thyroid gland is cost-effective and should be part of periodic examinations for people over age 35, especially women, a Johns Hopkins-led study suggests. The findings contradict current recommendations by most physician groups that such thyroid screenings are unnecessary in the general population.

Routine thyroid screenings may prevent a mild problem from becoming severe, reverse severe symptoms that have gone undiagnosed and lower thyroid-related high blood cholesterol, a major factor in heart disease, according to the results. The study, which used a computer model and statistical analysis to make cost-and-benefit predictions for mild thyroid failure screenings for the U.S. population, was supported by the National Institutes of Health, Forest Laboratories and Corning Clinical Laboratories.

"Early detection and treatment of mild thyroid failure can enhance the quality and even the duration of life," says Paul W. Ladenson, M.D., lead author and director of endocrinology and metabolism at Hopkins. "Our findings suggest that the health benefits are worth the costs and that these screenings could be as safe, inexpensive and effective as other common preventative tests in detecting early or hidden problems."

The results are published in the July 24 issue of the Journal of the American Medical Association.

Researchers calculated the cost-effectiveness and impact on quality of life when people were screened every five years beginning at age 35 and received four decades of follow-up medication and care. The results show the average screening costs to improve quality of life for people with mild hypothyroidism, or underproduction of thyroid hormones, are comparable to screening costs for other disorders such as high blood pressure, breast cancer and high blood cholesterol.

The results show that quality of life for hypothyroid patients improves through the relief of symptoms, such as fatigue, weight gain and depression, while the greatest cost savings come from lowering cholesterol and the related risk of heart disease. The hypothyroidism screenings become more cost-effective as the patients grow older, especially for women.

The quality of life formula took into account direct costs, such as examinations, tests, medications and long-term care, and intangible factors, such as the number of lives saved, years of life saved, complications and their severity, and years spent with the disorder undiagnosed or diagnosed and treated.

Mild hypothyroidism increases with age and affects up to 15 percent of older women and 10 percent of older men. The thyroid gland, a butterfly-shaped organ in the neck and a key part of the endocrine system, produces hormones and helps regulate the body's metabolism. The screening measures the level of thyroid-stimulating hormone (TSH) in the blood.

The study's other authors were Mark D. Danese, B.A., and Neil R. Powe, M.D., of Hopkins and Clark T. Sawin, M.D., of the Department of Veterans Affairs Medical Center and the Boston University School of Medicine.

Johns Hopkins Medicine

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to